A chemokine-binding domain in the tumor necrosis factor receptor from variola (smallpox) virus.

Variola virus (VaV) is the causative agent of smallpox, one of the most devastating diseases encountered by man, that was eradicated in 1980. The deliberate release of VaV would have catastrophic consequences on global public health. However, the mechanisms that contribute to smallpox pathogenesis are poorly understood at the molecular level. The ability of viruses to evade the host defense mechanisms is an important determinant of viral pathogenesis. Here we show that the tumor necrosis factor receptor (TNFR) homologue CrmB encoded by VaV functions not only as a soluble decoy TNFR but also as a highly specific binding protein for several chemokines that mediate recruitment of immune cells to mucosal surfaces and the skin, sites of virus entry and viral replication at late stages of smallpox. CrmB binds chemokines through its C-terminal domain, which is unrelated to TNFRs, was named smallpox virus-encoded chemokine receptor (SECRET) domain and uncovers a family of poxvirus chemokine inhibitors. An active SECRET domain was found in another viral TNFR (CrmD) and three secreted proteins encoded by orthopoxviruses. These findings identify a previously undescribed chemokine-binding and inhibitory domain unrelated to host chemokine receptors and a mechanism of immune modulation in VaV that may influence smallpox pathogenesis.

[1]  Á. Zaballos,et al.  Cutting edge: identification of the orphan chemokine receptor GPR-9-6 as CCR9, the receptor for the chemokine TECK. , 1999, Journal of immunology.

[2]  D A Henderson,et al.  The looming threat of bioterrorism. , 1999, Science.

[3]  A. Alcamí,et al.  Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. , 1998, Journal of immunology.

[4]  A. Alcamí,et al.  Expression of Secreted Cytokine and Chemokine Inhibitors by Ectromelia Virus , 2000, Journal of Virology.

[5]  V N Loparev,et al.  Alastrim smallpox variola minor virus genome DNA sequences. , 2000, Virology.

[6]  D. Wiley,et al.  Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  H. Soto,et al.  CCL27–CCR10 interactions regulate T cell–mediated skin inflammation , 2002, Nature Medicine.

[8]  S. Shchelkunov,et al.  Comparison of the genome DNA sequences of Bangladesh-1975 and India-1967 variola viruses. , 1995, Virus research.

[9]  A. Kerlavage,et al.  Potential virulence determinants in terminal regions of variola smallpox virus genome , 1993, Nature.

[10]  D. Relman,et al.  Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. McFadden,et al.  Smallpox: anything to declare? , 2002, Nature Reviews Immunology.

[12]  Antonio Alcami,et al.  Viral mimicry of cytokines, chemokines and their receptors , 2003, Nature Reviews Immunology.

[13]  D. Fremont,et al.  Identification of a Gammaherpesvirus Selective Chemokine Binding Protein That Inhibits Chemokine Action , 2000, Journal of Virology.

[14]  P. Jahrling,et al.  Virulence differences between monkeypox virus isolates from West Africa and the Congo basin , 2005, Virology.

[15]  F. Fenner.  Smallpox and its eradication , 1988 .

[16]  G. McFadden,et al.  Poxviruses and immune evasion. , 2003, Annual review of immunology.

[17]  C. McMaster,et al.  CXCR3 is required for migration to dermal inflammation by normal and in vivo activated T cells: differential requirements by CD4 and CD8 memory subsets , 2005, European journal of immunology.

[18]  G. McFadden,et al.  The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. , 1997, Virology.

[19]  M. Gerhart,et al.  Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. , 1997, Virology.

[20]  C. Smith,et al.  Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. , 1996, Virology.

[21]  G. McFadden,et al.  Mutational analysis of the ligand-binding domain of M-T2 protein, the tumor necrosis factor receptor homologue of myxoma virus. , 1996, Journal of immunology.

[22]  Lisa M. Ebert,et al.  Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. , 2005, Immunity.

[23]  L. Steinman,et al.  Design of effective immunotherapy for human autoimmunity , 2005, Nature.

[24]  C. Smith,et al.  Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. , 1994, Virology.

[25]  Geoffrey L. Smith,et al.  Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence. , 2002, Virology.

[26]  A. Alcamí,et al.  Glycoprotein G isoforms from some alphaherpesviruses function as broad‐spectrum chemokine binding proteins , 2003, The EMBO journal.

[27]  T. Shenk,et al.  Human cytomegalovirus encodes a highly specific RANTES decoy receptor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Eric J Kunkel,et al.  Chemokines and the tissue-specific migration of lymphocytes. , 2002, Immunity.

[29]  E. A. Uvarova,et al.  Analysis of the Monkeypox Virus Genome , 2002, Virology.

[30]  P. Kellam,et al.  Poxvirus genomes: a phylogenetic analysis. , 2004, The Journal of general virology.

[31]  Geoffrey L. Smith,et al.  The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. , 2002, The Journal of general virology.

[32]  A. Alcamí,et al.  Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. , 1999, The Journal of general virology.

[33]  E. Kunkel,et al.  The Intestinal Chemokine Thymus-expressed Chemokine (CCL25) Attracts IgA Antibody-secreting Cells , 2002, The Journal of experimental medicine.

[34]  A. Alcamí,et al.  CrmE, a Novel Soluble Tumor Necrosis Factor Receptor Encoded by Poxviruses , 2001, Journal of Virology.

[35]  J. Panus,et al.  A third distinct tumor necrosis factor receptor of orthopoxviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Tracy M. Handel,et al.  Structural Basis of Chemokine Sequestration by a Herpesvirus Decoy Receptor , 2002, Cell.

[37]  David J Esteban,et al.  Interleukin-18 and glycosaminoglycan binding by a protein encoded by Variola virus. , 2004, The Journal of general virology.

[38]  N. Lukacs,et al.  Temporal production of CCL28 corresponds to eosinophil accumulation and airway hyperreactivity in allergic airway inflammation. , 2005, The American journal of pathology.

[39]  A. Alcamí,et al.  A Broad Spectrum Secreted Chemokine Binding Protein Encoded by a Herpesvirus , 2000, Journal of Experimental Medicine.

[40]  E. Kunkel,et al.  A Common Mucosal Chemokine (Mucosae-Associated Epithelial Chemokine/CCL28) Selectively Attracts IgA Plasmablasts 1 , 2003, The Journal of Immunology.